Literature DB >> 9663718

Review article: bone and joint diseases in inflammatory bowel disease.

M De Vos1, F De Keyser, H Mielants, C Cuvelier, E Veys.   

Abstract

The intestinal and articular systems are closely linked in inflammatory bowel disease. Clinical and immunological studies support an important aetio-pathogenetic link between intestinal and articular inflammation. There is increasing evidence for a negative link between bone mass density and intestinal inflammation. This paper will focus on the prevalence, aetio-pathogenesis and treatment of arthritis (peripheral, sacroiliitis and spondylitis) and osteoporosis in inflammatory bowel disease.

Entities:  

Mesh:

Year:  1998        PMID: 9663718     DOI: 10.1046/j.1365-2036.1998.00325.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  4 in total

Review 1.  Clinical aspects and pathophysiology of inflammatory bowel disease.

Authors:  Barbara A Hendrickson; Ranjana Gokhale; Judy H Cho
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

2.  Peripheral arthritis in the course of inflammatory bowel diseases.

Authors:  Ilhami Yüksel; Hilmi Ataseven; Omer Başar; Seyfettin Köklü; Ibrahim Ertuğrul; Aysel Ulker; Ulkü Dağlı; Nurgül Saşmaz
Journal:  Dig Dis Sci       Date:  2010-05-11       Impact factor: 3.199

3.  Reduced systemic IgG levels against peptidoglycan in rheumatoid arthritis (RA) patients.

Authors:  I A Schrijver; Y A De Man; M J Melief; J M Van Laar; H M Markusse; I S Klasen; M P Hazenberg; J D Laman
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

Review 4.  The genetic backbone of ankylosing spondylitis: how knowledge of genetic susceptibility informs our understanding and management of disease.

Authors:  Marcus Kenyon; Sinead Maguire; Anna Rueda Pujol; Finbar O'Shea; Ross McManus
Journal:  Rheumatol Int       Date:  2022-08-08       Impact factor: 3.580

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.